Selected research
Industry Research
Oral Contraceptive Drugs Industry Research Report 2026
Market perspective
The global Oral Contraceptive Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Oral Contraceptive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Oral Contraceptive Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Oral Contraceptive Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Oral Contraceptive Drugs include Teva Pharmaceutical, Johnson & Johnson, Baijingyu, Merck, Pfizer, Bayer, ZiZhu, Novo Nordisk A/S and Huazhong, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Oral Contraceptive Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oral Contraceptive Drugs Market by Company
Teva Pharmaceutical
Johnson & Johnson
Baijingyu
Merck
Pfizer
Bayer
ZiZhu
Novo Nordisk A/S
Huazhong
Gedeon Richter
Actavis
Oral Contraceptive Drugs Segment by Type
Short-acting Contraceptives
Emergency Contraceptives
Long-acting Contraceptives
Oral Contraceptive Drugs Segment by Application
Hospital
Pharmacy
Other
Oral Contraceptive Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Contraceptive Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Contraceptive Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Contraceptive Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oral Contraceptive Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oral Contraceptive Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oral Contraceptive Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Short-acting Contraceptives
- Emergency Contraceptives
- Long-acting Contraceptives
Applications
- Hospital
- Pharmacy
- Other
Companies covered
- Teva Pharmaceutical
- Johnson & Johnson
- Baijingyu
- Merck
- Pfizer
- Bayer
- ZiZhu
- Novo Nordisk A/S
- Huazhong
- Gedeon Richter
- Actavis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Oral Contraceptive Drugs Market Size (2021-2032)
- 2.2.2 Global Oral Contraceptive Drugs Sales (2021-2032)
- 2.2.3 Global Oral Contraceptive Drugs Market Average Price (2021-2032)
- 2.3 Oral Contraceptive Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Short-acting Contraceptives
- 2.3.3 Emergency Contraceptives
- 2.3.4 Long-acting Contraceptives
- 2.4 Oral Contraceptive Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Pharmacy
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Oral Contraceptive Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Oral Contraceptive Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Oral Contraceptive Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Oral Contraceptive Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Oral Contraceptive Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Oral Contraceptive Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Oral Contraceptive Drugs, Product Type & Application
- 3.8 Global Manufacturers of Oral Contraceptive Drugs, Established Date
- 3.9 Global Oral Contraceptive Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical
- 4.1.1 Teva Pharmaceutical Company Information
- 4.1.2 Teva Pharmaceutical Business Overview
- 4.1.3 Teva Pharmaceutical Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Oral Contraceptive Drugs Product Portfolio
- 4.1.5 Teva Pharmaceutical Recent Developments
- 4.2 Johnson & Johnson
- 4.2.1 Johnson & Johnson Company Information
- 4.2.2 Johnson & Johnson Business Overview
- 4.2.3 Johnson & Johnson Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson & Johnson Oral Contraceptive Drugs Product Portfolio
- 4.2.5 Johnson & Johnson Recent Developments
- 4.3 Baijingyu
- 4.3.1 Baijingyu Company Information
- 4.3.2 Baijingyu Business Overview
- 4.3.3 Baijingyu Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Baijingyu Oral Contraceptive Drugs Product Portfolio
- 4.3.5 Baijingyu Recent Developments
- 4.4 Merck
- 4.4.1 Merck Company Information
- 4.4.2 Merck Business Overview
- 4.4.3 Merck Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merck Oral Contraceptive Drugs Product Portfolio
- 4.4.5 Merck Recent Developments
- 4.5 Pfizer
- 4.5.1 Pfizer Company Information
- 4.5.2 Pfizer Business Overview
- 4.5.3 Pfizer Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pfizer Oral Contraceptive Drugs Product Portfolio
- 4.5.5 Pfizer Recent Developments
- 4.6 Bayer
- 4.6.1 Bayer Company Information
- 4.6.2 Bayer Business Overview
- 4.6.3 Bayer Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Bayer Oral Contraceptive Drugs Product Portfolio
- 4.6.5 Bayer Recent Developments
- 4.7 ZiZhu
- 4.7.1 ZiZhu Company Information
- 4.7.2 ZiZhu Business Overview
- 4.7.3 ZiZhu Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 ZiZhu Oral Contraceptive Drugs Product Portfolio
- 4.7.5 ZiZhu Recent Developments
- 4.8 Novo Nordisk A/S
- 4.8.1 Novo Nordisk A/S Company Information
- 4.8.2 Novo Nordisk A/S Business Overview
- 4.8.3 Novo Nordisk A/S Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Novo Nordisk A/S Oral Contraceptive Drugs Product Portfolio
- 4.8.5 Novo Nordisk A/S Recent Developments
- 4.9 Huazhong
- 4.9.1 Huazhong Company Information
- 4.9.2 Huazhong Business Overview
- 4.9.3 Huazhong Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Huazhong Oral Contraceptive Drugs Product Portfolio
- 4.9.5 Huazhong Recent Developments
- 4.10 Gedeon Richter
- 4.10.1 Gedeon Richter Company Information
- 4.10.2 Gedeon Richter Business Overview
- 4.10.3 Gedeon Richter Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Gedeon Richter Oral Contraceptive Drugs Product Portfolio
- 4.10.5 Gedeon Richter Recent Developments
- 4.11 Actavis
- 4.11.1 Actavis Company Information
- 4.11.2 Actavis Business Overview
- 4.11.3 Actavis Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Actavis Oral Contraceptive Drugs Product Portfolio
- 4.11.5 Actavis Recent Developments
5 Global Oral Contraceptive Drugs Market Scenario by Region
- 5.1 Global Oral Contraceptive Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Oral Contraceptive Drugs Sales by Region: 2021-2032
- 5.2.1 Global Oral Contraceptive Drugs Sales by Region: 2021-2026
- 5.2.2 Global Oral Contraceptive Drugs Sales by Region: 2027-2032
- 5.3 Global Oral Contraceptive Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Oral Contraceptive Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Oral Contraceptive Drugs Revenue by Region: 2027-2032
- 5.4 North America Oral Contraceptive Drugs Market Facts & Figures by Country
- 5.4.1 North America Oral Contraceptive Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Oral Contraceptive Drugs Sales by Country (2021-2032)
- 5.4.3 North America Oral Contraceptive Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Oral Contraceptive Drugs Market Facts & Figures by Country
- 5.5.1 Europe Oral Contraceptive Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Oral Contraceptive Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Oral Contraceptive Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Oral Contraceptive Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Oral Contraceptive Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Oral Contraceptive Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Oral Contraceptive Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Oral Contraceptive Drugs Market Facts & Figures by Country
- 5.7.1 South America Oral Contraceptive Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Oral Contraceptive Drugs Sales by Country (2021-2032)
- 5.7.3 South America Oral Contraceptive Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Oral Contraceptive Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Oral Contraceptive Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Oral Contraceptive Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Oral Contraceptive Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Oral Contraceptive Drugs Sales by Type (2021-2032)
- 6.1.1 Global Oral Contraceptive Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Oral Contraceptive Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Oral Contraceptive Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Oral Contraceptive Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Oral Contraceptive Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Oral Contraceptive Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Oral Contraceptive Drugs Sales by Application (2021-2032)
- 7.1.1 Global Oral Contraceptive Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Oral Contraceptive Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Oral Contraceptive Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Oral Contraceptive Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Oral Contraceptive Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Oral Contraceptive Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Oral Contraceptive Drugs Value Chain Analysis
- 8.1.1 Oral Contraceptive Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Oral Contraceptive Drugs Production Mode & Process
- 8.2 Oral Contraceptive Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Oral Contraceptive Drugs Distributors
- 8.2.3 Oral Contraceptive Drugs Customers
9 Global Oral Contraceptive Drugs Analyzing Market Dynamics
- 9.1 Oral Contraceptive Drugs Industry Trends
- 9.2 Oral Contraceptive Drugs Industry Drivers
- 9.3 Oral Contraceptive Drugs Industry Opportunities and Challenges
- 9.4 Oral Contraceptive Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst